Voyager Therapeutics (VYGR) Reports Q2 Loss, Tops Revenue Estimates

Voyager Therapeutics (VYGR) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of$ 0.38. This compares to loss of $0.51 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 52.63%. A quarter ago, it was expected that this gene therapy company would post a loss of$ 0.44 per share when it actually produced a loss of $0.20, delivering a surprise of 54.55%. Over the last four quarters, the ...